Frontline therapy with high-dose imatinib versus second generation tyrosine kinase inhibitor in patients with chronic-phase chronic myeloid leukemia - a propensity score analysis
一线治疗慢性期慢性粒细胞白血病患者,高剂量伊马替尼与第二代酪氨酸激酶抑制剂的疗效比较——倾向评分分析
期刊:Haematologica
影响因子:7.9
doi:10.3324/haematol.2015.139089
Sasaki, Koji; Kantarjian, Hagop; Jabbour, Elias; Ravandi, Farhad; Takahashi, Koichi; Konopleva, Marina; Borthakur, Gautam; Garcia-Manero, Guillermo; Wierda, William; Daver, Naval; Jain, Preetesh; Satta, Toshihisa; Pierce, Sherry; Rios, May Beth; Cortes, Jorge E